We demonstrated that FXR plays an important role in OCA-induced liver fibrosis when OCA is administered at high dose or in conditions of advanced cirrhosis, the latter of which resulted in a sharp increase in OCA plasma concentrations (Edwards et al., 2016). The gene discussed is NR1H4; the disease is Cirrhosis.